Cargando…

Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis

Background. Serum cystatin C (CysC) was proposed as an effective reflection of the glomerular filtration rate (GFR). However, its role in patients with liver cirrhosis has not been extensively verified especially in the detection of early RI. Patients and Methods. Seventy consecutive potential candi...

Descripción completa

Detalles Bibliográficos
Autores principales: Omar, Mahmoud, Abdel-Razek, Wael, Abo-Raia, Gamal, Assem, Medhat, El-Azab, Gasser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621358/
https://www.ncbi.nlm.nih.gov/pubmed/26550493
http://dx.doi.org/10.1155/2015/309042
_version_ 1782397425651023872
author Omar, Mahmoud
Abdel-Razek, Wael
Abo-Raia, Gamal
Assem, Medhat
El-Azab, Gasser
author_facet Omar, Mahmoud
Abdel-Razek, Wael
Abo-Raia, Gamal
Assem, Medhat
El-Azab, Gasser
author_sort Omar, Mahmoud
collection PubMed
description Background. Serum cystatin C (CysC) was proposed as an effective reflection of the glomerular filtration rate (GFR). However, its role in patients with liver cirrhosis has not been extensively verified especially in the detection of early RI. Patients and Methods. Seventy consecutive potential candidates for living donor liver transplantation with serum creatinine (Cr) <1.5 mg/dL were included. CysC, Cr, and estimated GFR [creatinine clearance (CCr), Cockcroft-Gault formula (C-G), MDRD equations with 4 and 6 variables, CKD-EPI-Cr, CKD-EPI-CysC, and CKD-EPI-Cr-CysC] were all correlated to isotopic GFR. Early RI was defined as GFR of 60–89 mL/min/1.73 m(2). Results. Patients were 25.7% and 74.3% Child-Pugh classes B and C, respectively. GFR was ≥90, 60–89, and 30–59 mL/min/1.73 m(2) in 31.4%, 64.3%, and 4.3% of the patients, respectively. All markers and equations, except C-G, were significantly correlated to GFR with CKD-EPI-Cr-CysC formula having the highest correlation (r = 0.474) and the largest area under the ROC curve (0.808) for discriminating early RI. At a cutoff value of 1.2 mg/L, CysC was 89.6% sensitive and 63.6% specific in detecting early RI. Conclusion. In patients with liver cirrhosis, CysC and CysC-based equations showed the highest significant correlation to GFR and were measures that best discriminated early RI.
format Online
Article
Text
id pubmed-4621358
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-46213582015-11-08 Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis Omar, Mahmoud Abdel-Razek, Wael Abo-Raia, Gamal Assem, Medhat El-Azab, Gasser Int J Hepatol Research Article Background. Serum cystatin C (CysC) was proposed as an effective reflection of the glomerular filtration rate (GFR). However, its role in patients with liver cirrhosis has not been extensively verified especially in the detection of early RI. Patients and Methods. Seventy consecutive potential candidates for living donor liver transplantation with serum creatinine (Cr) <1.5 mg/dL were included. CysC, Cr, and estimated GFR [creatinine clearance (CCr), Cockcroft-Gault formula (C-G), MDRD equations with 4 and 6 variables, CKD-EPI-Cr, CKD-EPI-CysC, and CKD-EPI-Cr-CysC] were all correlated to isotopic GFR. Early RI was defined as GFR of 60–89 mL/min/1.73 m(2). Results. Patients were 25.7% and 74.3% Child-Pugh classes B and C, respectively. GFR was ≥90, 60–89, and 30–59 mL/min/1.73 m(2) in 31.4%, 64.3%, and 4.3% of the patients, respectively. All markers and equations, except C-G, were significantly correlated to GFR with CKD-EPI-Cr-CysC formula having the highest correlation (r = 0.474) and the largest area under the ROC curve (0.808) for discriminating early RI. At a cutoff value of 1.2 mg/L, CysC was 89.6% sensitive and 63.6% specific in detecting early RI. Conclusion. In patients with liver cirrhosis, CysC and CysC-based equations showed the highest significant correlation to GFR and were measures that best discriminated early RI. Hindawi Publishing Corporation 2015 2015-10-13 /pmc/articles/PMC4621358/ /pubmed/26550493 http://dx.doi.org/10.1155/2015/309042 Text en Copyright © 2015 Mahmoud Omar et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Omar, Mahmoud
Abdel-Razek, Wael
Abo-Raia, Gamal
Assem, Medhat
El-Azab, Gasser
Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
title Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
title_full Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
title_fullStr Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
title_full_unstemmed Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
title_short Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
title_sort evaluation of serum cystatin c as a marker of early renal impairment in patients with liver cirrhosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621358/
https://www.ncbi.nlm.nih.gov/pubmed/26550493
http://dx.doi.org/10.1155/2015/309042
work_keys_str_mv AT omarmahmoud evaluationofserumcystatincasamarkerofearlyrenalimpairmentinpatientswithlivercirrhosis
AT abdelrazekwael evaluationofserumcystatincasamarkerofearlyrenalimpairmentinpatientswithlivercirrhosis
AT aboraiagamal evaluationofserumcystatincasamarkerofearlyrenalimpairmentinpatientswithlivercirrhosis
AT assemmedhat evaluationofserumcystatincasamarkerofearlyrenalimpairmentinpatientswithlivercirrhosis
AT elazabgasser evaluationofserumcystatincasamarkerofearlyrenalimpairmentinpatientswithlivercirrhosis